Progressive change agent with deep expertise in leading high performing teams, delivering innovative business strategy, and creating advocacy models transforming the way patients gain access to treatments. Proven innovator and trusted business partner who solves complex business, patient, and physician problems. Global pharmaceutical leadership experience spanning clinical operations, medical affairs, and research. Highly reputable advisor in the following therapeutic areas: Cardiovascular, Oncology, Immunoscicence, and Virology.
Notable for designing and implementing global, disruptive integrated recruitment engagement strategies. Diversity thought leader and community advocate with a focus on advancing the careers of women.
Alan Yeomans has worked with the development of computerised systems for 40 years as hardware designer, programmer, system architect, project manager and in a number of management roles including CTO and QM.
Alan has been at Viedoc Technologies since late 2008, where he is responsible for Quality Assurance of their EDC vendor business. From 2008-2014 he was also responsible for Quality Assurance for their CRO business, until that part of the company was organised as a separate entity. Alan has earlier worked as CTO for a Swedish CRO (CDC) and as CTO and QM for an international ePRO provider (Clinitrac).
Alan worked at British Aerospace, Space and Communications Division from 1981 to 1984 as a hardware designer on control systems for communications satellites. While there he developed the first CPU-board used in control systems on their communications satellites.
After moving to Sweden in 1984 Alan started working with software development, starting with hardware driver routines and moving up through the software architecture to all levels, including user interface software and database software.
Iain joined EastHORN in 2013 to play a key role in the next stages of EastHORN’s ambitious plans for growth. He has been managing CRO business development in Europe and North America for more than 15 years. Since the first tentative steps into Poland and Hungary in the 90’s he has enjoyed and been a key part of the spectacular growth in clinical services in this region and beyond. Senior management roles as European Head and Global VP of Business Development have enabled Iain to be at the leading edge of business and corporate development within the global CRO industry.
Iain is based in the UK and graduated in Cell Biology from the University of Glasgow.
Kaitlyn Townsley is the Associate Director of Product Innovation at Axiom Real-Time Metrics Inc., where she continually innovates Fusion eClinical Suite and related technologies to support the evolving technological needs of Clinical Trials as Studies increase in complexity, maintaining the balance between an easy and intuitive platform, and providing Sponsors with the complex tools they require to run their Clinical Programs.
Jim Kremidas is currently the Executive Director for ACRP, a not-for profit association the represents the clinical research enterprise. Prior to that he conducted consulting services for a variety of clients including support for investigator sites, academic institutions, sponsors and sup-pliers. He was the SVP of Patient Recruitment at two different large CROs for over 6 years where he and his team were responsible for de-veloping and implementing patient enrollment strategies for global clin-ical trials. Prior to that, he spent 24 years with Eli Lilly and Company. From 1999 to 2008 he led their clinical trial patient recruitment and re-tention efforts. In this role, he focused on predicting and accelerating the enrollment rates for all corporate studies. While in Strategic Sourc-ing he was responsible for the outsourcing of clinical development pro-jects to strategic suppliers including CRO’s, scientific staffing firms and Patient Recruitment Suppliers. Before his assignment in clinical devel-opment strategic sourcing, Mr. Kremidas led Lilly’s efforts to select and establish relationships with direct to consumer and professional adver-tising agencies, as well as, implement standardized processes for the de-velopment and implementation of marketing materials.
He is on the advisory board of CISCRP (a non-profit organization fo-cused on enhancing patient participation in clinical trials) and is also a volunteer for the Clinical Trial Transformation Initiative (CTTI) with Duke and the FDA. He is a frequent presenter at Industry Conferences and his articles/papers have been published in a wide variety of trade journals
Michael Causey is Editor-in-Chief at the Association of Clinical Research Professionals, where he oversees the peer-review journal, Clinical Researcher, and a weekly news publi-cation, CRbeat. He also hosts the “Spotlight On…” series on ACRPtv. Previously, he was a journalist and Editorial Director at FDAnews, where he ran the newsroom.
